Get started
Author

Mutaz Jamal Al‐Khreisat

Observed names: Al-Khreisat, Mutaz Jamal, Mutaz Al-Khreisat, Mutaz Jamal Al-Khreisat, Mutaz Jamal Al-khreisat, Mutaz Jamal Al‐khreisat, Mutaz Jamal-Al-khreisat, Mutaz Jamal Al‐khreisat
ORCID: 0000-0003-0081-1092
Observed ORCID: 0000-0003-0081-1092
OpenAlex ID: A5074539771
Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma
2023 · Nor Hayati Ismail, Ali Mussa, et al. · Non-Coding RNA · 32
The Role of Epigenetics in the Development and Progression of Multiple Myeloma
2022 · Nor Hayati Ismail, Ali Mussa, et al. · Biomedicines · 28
PDF
Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
2023 · Mutaz Jamal Al-Khreisat, Nor Hayati Ismail, et al. · Diagnostics · 24
PDF
The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis
2023 · Nor Hayati Ismail, Ali Mussa, et al. · Nutrients · 22
PDF
The impact of wet cupping on haematological and inflammatory parameters in a sample of Jordanian team players
2024 · Ali Abdelfattah, Ayed Zureigat, et al. · Heliyon · 15
Targeting cancer stem cell plasticity and tumor microenvironment crosstalk: a comprehensive review
2025 · Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, et al. · Discover Oncology · 13
Diminishing Hepcidin via Reducing IL-6/STAT3 Pathway by Utilizing Ferulic Acid: An In Vitro Study
2025 · Ola M. Al-Sanabra, Luay F. Abu-Qatouseh, et al. · Biomedicines · 11
PDF
The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
2022 · Mutaz Jamal Al-Khreisat, Faezahtul Arbaeyah Hussain, et al. · Cancers · 9
PDF
Role of MicroRNAs in Inflammatory Joint Diseases: A Review
2023 · Nazmul Huda Syed, Ali Mussa, et al. · Immunological Investigations · 8
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review
2023 · Nor Hayati Ismail, Ali Mussa, et al. · Diagnostics · 6
PDF
Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety
2026 · Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, et al. · Discover Oncology · 3
Circulating Tumor Cells as Diagnostic and Therapeutic Biomarkers in Hepatocellular Carcinoma: Advancing Precision Oncology Through Liquid Biopsy
2026 · Mutaz Jamal Al‐khreisat, Munthar Kadhim‐Abosaoda, et al. · Journal of Gastroenterology and Hepatology · 3
PDF
Correlation Between Vitamin D and TSH Levels in Healthy Controls and Individuals with Hypothyroidism According to Age and Sex
2025 · Sara Abaza, Diya Hasan, et al. · Acta Informatica Medica · 3
Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy
2026 · Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, et al. · Annals of Hematology · 2
PDF
Monocyte‐To‐Lymphocyte Ratio as a Predictor of Thrombosis Progression in Patients With Polycythemia Vera: A Retrospective Study
2025 · Ali Abdelfattah, Ghufran S. Issa, et al. · International Journal of Laboratory Hematology · 2
Comprehensive Expression of Long non-coding RNAs and association with the Iron and Erythropoiesis Regulatory Proteins in Transfusion-dependent β-Thalassemia
2025 · Ola M. Al-Sanabra, Wafa' J. Haza, et al. · Archives of Medical Science · 2
PDF
Phenotypic Variability and Hematological Characterization of β0- and β+-Thalassemia Carriers: A Comparative Study
2025 · Ahmad Al Tibi, Diya Hasan, et al. · Journal of Clinical Medicine Research · 2
PDF
The CREM–IL-15 axis: decoding the persistence–exhaustion paradox in NK cell immunotherapy
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Mutaz Jamal Al-khreisat, et al. · Cancer Immunology Immunotherapy · 1
PDF
Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Mutaz Jamal Al-khreisat, et al. · Clinical and Experimental Medicine · 1
Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins
2026 · Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, et al. · Discover Oncology · 1
Non-coding RNAs as emerging biomarkers in melanoma
2026 · Qamar Abuhassan, Mutaz Jamal Al-khreisat, et al. · Clinica Chimica Acta · 1
Next-generation dendritic cell and exosome vaccines in NSCLC: integrating personalized medicine, nanotechnology, AI, and microfluidics for enhanced immunotherapy
2026 · Mutaz Jamal Al-Khreisat, Alaa Khalaf Bediwi, et al. · Immunotherapy
Convergent node, divergent failure: GPX4–SLC7A11–GSH ferroptosis as a unifying, tissue-decoded axis of diabetic complications
2026 · Mutaz Jamal Al-khreisat, Sarah Qutayba Badraldin, et al. · The Journal of Steroid Biochemistry and Molecular Biology
Hypoxia-induced epigenetic reprogramming of cancer stem cells: Linking stemness, metastasis, and therapy resistance
2026 · Mutaz Jamal Al-khreisat, Rustam Narzikulov, et al. · Gene
Pyroptosis in triple-negative breast cancer: From inflammasome signaling to tumor immune remodeling and translational therapeutic strategies
2026 · Qamar Abuhassan, Mutaz Jamal Al-khreisat, et al. · Progress in Biophysics and Molecular Biology
Works count: 31
Citation count: 189
H-index: 8
I10-index: 7
Year
Topic
Type